Because of this, healthcare providers have utilized Semaglutide for over 15 years to treat Type 2 diabetes effectively
Poster Session II - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.03 - HYPERACUTE MANAGEMENT P667 - ESOC25-2238 DIAGNOSTIC ACCURACY OF POINT-OF-CARE VISCOELASTIC ASSESSMENT OF DIRECT ORAL ANTICOAGULATION IN ACUTE ISCHEMIC STROKE: INTERIM RESULTS FROM A PROSPECTIVE VALIDATION STUDY Annahita Sedghi 1 , Eva Meyer-Bender 1 , Lars Heubner 2 , Joerg Pietsch 3 , Oliver Tiebel 4 , Kristian Barlinn 1 , Jan Beyer-Westendorf 5 , Volker Puetz 1 , Peter Spieth 2 , Timo Siepmann 1 1 Dresden Neurovascular Center, Department of Neurology, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 2 Department of Anesthesiology and Intensive Care Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 3 Institute of Legal Medicine, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 4 Institute of Clinical Chemistry, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany, 5 Thrombosis Research Unit, Department of Medicine I, Medical Faculty and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, Dresden, Germany Background and Aims: Intravenous thrombolysis in patients with acute ischemic stroke (AIS) is often delayed because of uncertainty about the presence of direct oral anticoagulants (DOACs)
Further, the injection medicine combines lidocaine and a saline solution with the steroid to help numb your pain and flush out potential inflammatory proteins and chemicals that may be present in the dura sac
Wu DC, Fletcher L, Guiha I , Goldman MP
